Advisers Latest

Big pharma has been hungry for ways to replace blockbusters that are losing steam, as patents face expiration dates.

Alternative "leagues" that leverage bad rules to a competitive advantage at the expense of others must be eliminated.

The drugmaker's new platform connects patients with doctors who can prescribe medications and provide home delivery of certain drugs.

Fixed medical indemnity plans represent an affordable option for low-wage and part-time employees.

Data shows that the $5,000 annual tax limit does not cover the average price of one child in center-based infant care.

When pharmacists can collaborate with a patient's care team, health outcomes will improve while money and lives are saved.

In the wake of a hastily drafted law that leaves plan sponsors with questions, the goal is to be "as compliant as possible."

The nation's largest hospital system has been cited for failing to make prices fully available to the public

A new rule will allow long-term, part-time employees to contribute to retirement plans by 2025.

This type of drug activates anti-inflammatory pathways in the brain with far-reaching effects that may independently keep the heart healthy.